Authors: Schiller, JH Adak, S Feins, RH Keller, SM Fry, WA Livingston, RB Hammond, MEM Wolf, B Sabatini, L Jett, J Kohman, L Johnson, DH

Citation: Jh. Schiller et al., Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: A laboratory ancillary study on an Eastern Cooperative Oncology Group prospective randomized trial of postoperative adjuvant therapy, J CL ONCOL, 19(2), 2001, pp. 448-457

Authors: Marrogi, AJ Travis, WD Welsh, JA Khan, MA Rahim, H Tazelaar, H Pairolero, P Trastek, V Jett, J Caporaso, NE Liotta, LA Harris, CC

Citation: Aj. Marrogi et al., Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma, CLIN CANC R, 6(12), 2000, pp. 4739-4744

Authors: Adjei, AA Erlichman, C Sloan, JA Reid, JM Pitot, HC Goldberg, RM Peethambaram, P Atherton, P Hanson, LJ Alberts, SR Jett, J

Citation: Aa. Adjei et al., Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumors, J CL ONCOL, 18(8), 2000, pp. 1748-1757

Authors: Levitan, N Dowlati, A Shina, D Craffey, M Mackay, W DeVore, R Jett, J Remick, SC Chang, A Johnson, D

Citation: N. Levitan et al., Multi-institutional phase I/II trial of paclitaxel, cisplatin, and etoposide with concurrent radiation for limited-stage small-cell lung carcinoma, J CL ONCOL, 18(5), 2000, pp. 1102-1109